Making a difference for Parkinson's disease research. My research improves patient care by unraveling the causes of neurodegeneration. 🌈🏃🏻♀️🧑🔬
Stanford, CA
Joined May 2014
- Tweets467
- Following3.6K
- Followers1.3K
- Likes1.6K
Our new Neurology Genetics paper shares preliminary evidence that ATXN10 motif architecture, not just expansion length, may influence onset in SCA10.
This is the first step. More sequencing, larger cohorts, and deeper analyses are coming.
neurology.org/doi/pdf/10.121…
New preprint on ATXN10 in Peruvian families show repeat motif patterns influence disease onset @PacBio @bionano @mario_cornejo_o researchsquare.com/article/r…
Exciting new study shows intermediate ATXN10 alleles in healthy Peruvian population. So much more to learn about repeat expansion disorders! researchsquare.com/article/r…
Now it's published in the journal The Cerebellum: link.springer.com/article/10…
Scrutinizing the KOLF2.1J iPSC line using @BionanoGenomics OGM. #OpenScience #iPSC #Genomics biorxiv.org/content/10.1101/…
Interested in joining our labs as a post-doc? @BrainResilience @StanfordPath @StanfordMed @Stanford_Neuro
We have an open position for a cell culture technician for an exciting new initiative to build a protein atlas for neurodegenerative diseases. Are you interested? Please see the link:
phxc1b.rfer.us/STANFORD3D1Qd…
Birgitt Schuele (She/her) retweeted
📣Please RT! Our lab @Stanford_Neuro has an immediate opening for a full-time Research Assistant studying biomarkers of neurodegenerative disease!
🔬🩸🥼
Fun & supportive training environment with fantastic colleagues!
For more info & to apply visit:
careersearch.stanford.edu/jo…
Looking forward to the Stem Cells in Neuroscience conference in Tuebingen next week! #StemCellTuebingen stemcelltuebingen.com/
Our Department of Pathology at Stanford University is seeking an exceptional scientist to join us as a tenure-line Assistant, Associate, or Full Professor.
@StanfordMed, @StanfordPath
Please share:
facultypositions.stanford.ed…
Are you interested in publishing your latest research in the field of gene therapy for neurodegeneration with @SciReports? There is a new collection, we just launched.
We deposited a CRISPR-edited alpha-synuclein gene dosage human iPSC model with @officialatcc supported by @MichaelJFoxOrg. I hope this will be a valuable tool for #Parkinsons research community.
atcc.org/blogs/2023/accelera…
If you attend #Sfn23, check out our poster on multiplex imaging of human post-mortem brain, LRRK2, Parkinson’s disease in collaboration with @AkoyaBio and supported by @MichaelJFoxOrg
Attending #SfN23? Don’t miss our posters on how our #spatialphenotyping solutions contribute to the progress in #glioblastoma & #Parkinsonsdisease research.
#SfN2023 @SfNtweets @OracleBio @abcam @Stanford @StJude @AdityaPratapa_ @Theo_BrainC_lab @TheDohertyInst @SchueleLab
Congratulations to Ale Morato Torres for winning a poster prize at the Stanford Pathology retreat @StanfordPath for her in vivo work - knockdown of human alpha-synuclein as a therapeutic strategy.
Birgitt Schuele (She/her) retweeted
New research from @DanutaSastre @SchueleLab & @StanfordMed colleagues provides proof-of-concept in vitro targeting of the SNCA gene promoter using a #CRISPR interference (CRISPRi) system to controllably repress #Parkinsons-associated alpha-synuclein
nature.com/articles/s41598-0…
The journey has an end! Thanks for everyone who supported this study! It could have been a lot easier and faster, if we can all focus on the science! nature.com/articles/s41598-0…
Birgitt Schuele (She/her) retweeted
My postdoc work is finally out! We used #CRISPR to lower alpha-synuclein in #Parkinsons #iPSC neurons, achieving functional recovery. #invivo work coming out soon from the team at @SchueleLab @StanfordMed pre-print here while in #PeerReview doi.org/10.1101/2023.01.24.5…
